Solid Biosciences Inc expected to post a loss of $2.67 a share - Earnings Preview

Solid Biosciences

28/10/2022 15:21

* Solid Biosciences Inc  SLDB.OQ   SLDB.O  is expected
to show a
fall in quarterly revenue when it reports  results on November 1
(estimated). 
    * The Charlestown Massachusetts-based  company is expected
to
report  a 66.8% decrease in revenue to $1.175 million from $3.54
million a year ago, according to the mean estimate from 4
analysts, based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Solid Biosciences
Inc is
for a loss of $2.67 per share. 
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Solid
Biosciences
Inc is $30​, above​ its last closing price of $0.45. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Jun. 30 2022  -3.07       -3.15      -3.30     Missed  -4.8
 Mar. 31 2022  -2.77       -2.76      -3.30     Missed  -19.6
 Dec. 31 2021              -2.91      -2.40     Beat    17.5​
 Sep. 30 2021  -2.99       -3.02      -2.40     Beat    20.6
 ​​Jun.        -2.80       -2.82      -2.55     Beat    9.7
 30 2021                                                
 Mar. 31 2021  -5.14       -4.86      -2.85     Beat    41.4​
 Dec. 31 2020  -3.75       -5.09      -4.65     Beat    8.6
 Sep. 30 2020  -5.64       -5.17      -6.60     Missed  -27.5
 This summary was machine generated October 28 at 14:21 GMT.  All
figures in US dollars  unless otherwise stated